Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Dmitrienko

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
Critical Care Medicine|August 13, 2005
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsisBernhardt G Zeiher, Jay Steingrub, Pierre-Francois Laterre, et al.
Journal of Biopharmaceutical Statistics|December 15, 2017
An enhanced mixture method for constructing gatekeeping procedures in clinical trialsGeorge Kordzakhia, Thomas Brechenmacher, Eiji Ishida, et al.
Biometrical Journal. Biometrische Zeitschrift|April 5, 2013
Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis planSue-Jane Wang, Frank Bretz, Alex Dmitrienko, et al.
Statistics in Medicine|June 27, 2015
Multiplicity in confirmatory clinical trials: a case study with discussion from a JSM panelSue-Jane Wang, Frank Bretz, Alex Dmitrienko, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2019
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
JACC. Clinical Electrophysiology|January 22, 2021
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19Thomas F O'Connell, Christopher J Bradley, Amr E Abbas, et al.
Critical Care Medicine|March 11, 2003
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureEdward Abraham, Chris Naum, Venkata Bandi, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Innovative approaches for designing and analyzing adaptive dose-ranging trialsBjörn Bornkamp, Frank Bretz, Alex Dmitrienko, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
Critical Care Medicine|August 13, 2005
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsisBernhardt G Zeiher, Jay Steingrub, Pierre-Francois Laterre, et al.
Journal of Biopharmaceutical Statistics|December 15, 2017
An enhanced mixture method for constructing gatekeeping procedures in clinical trialsGeorge Kordzakhia, Thomas Brechenmacher, Eiji Ishida, et al.
Biometrical Journal. Biometrische Zeitschrift|April 5, 2013
Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis planSue-Jane Wang, Frank Bretz, Alex Dmitrienko, et al.
Statistics in Medicine|June 27, 2015
Multiplicity in confirmatory clinical trials: a case study with discussion from a JSM panelSue-Jane Wang, Frank Bretz, Alex Dmitrienko, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2019
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
JACC. Clinical Electrophysiology|January 22, 2021
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19Thomas F O'Connell, Christopher J Bradley, Amr E Abbas, et al.
Critical Care Medicine|March 11, 2003
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureEdward Abraham, Chris Naum, Venkata Bandi, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Innovative approaches for designing and analyzing adaptive dose-ranging trialsBjörn Bornkamp, Frank Bretz, Alex Dmitrienko, et al.
Pageof 7